Abstract:In the largest cohort study to date, comprising 22 Thrombocytopenia 4 (THC4) patients from six families, five heterozygous missense CYCS variants, Gly42Ser, Tyr49His, Ala52Thr, Arg92Gly, and Leu99Val, were identified. Bioinformatics analysis classified these variants as pathogenic, affecting structure and function of the protein. Functional validation using a yeast model demonstrated that the Ala52Thr and Arg92Gly mutations impair oxidative growth and respiratory activities, confirming their adverse effects. This study also described the clinical phenotypes of this cohort, characterized by mild‐to‐moderate thrombocytopenia with normal platelet size and function, and minimal to no bleeding risk. This study establishes a potential correlation between specific regions of CYCS affected by mutations and the severity of thrombocytopenia, underscoring the variant‐specific functional impairments of CYCS. Summary Thrombocytopenia 4 (THC4) is an autosomal‐dominant thrombocytopenia caused by mutations in CYCS, the gene encoding cytochrome c (CYCS), a small haeme protein essential for electron transport in mitochondria and cell apoptosis. THC4 is considered an extremely rare condition since only a few patients have been reported so far. These subjects presented mild thrombocytopenia and no or mild bleeding tendency. In this study, we describe six Italian families with five different heterozygous missense CYCS variants: p.Gly42Ser and p.Tyr49His previously associated with THC4, and three novel variants (p.Ala52Thr, p.Arg92Gly, and p.Leu99Val), which have been classified as pathogenic by bioinformatics and segregation analyses. Moreover, we supported functional effects of p.Ala52Thr and p.Arg92Gly on oxidative growth and respiratory activity in a yeast model. The clinical characterization of the 22 affected individuals, the largest series of THC4 patients ever reported, showed that this disorder is characterized by mild‐to‐moderate thrombocytopenia, normal platelet size, and function, low risk of bleeding, and no additional clinical phenotypes associated with reduced platelet count. Finally, we describe a significant correlation between the region of CYCS affected by mutations and the extent of thrombocytopenia, which could reflect different degrees of impairment of CYCS functions caused by different pathogenetic variants.

A novel thrombocytopenia‐4‐causing CYCS gene variant decreases caspase activity: Three‐generation study

Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene

Apoptosis and platelet biogenesis: A new piece of information on a debated topic

A comprehensive guide through the fold and stability of cytochrome c with implications for disease

Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation

A large deletion in TSC2 causes tuberous sclerosis complex by dysregulating PI3K/AKT/mTOR signaling pathway

Cystathionine β-synthase deficiency: different changes in proteomes of thrombosis-resistant Cbs−/− mice and thrombosis-prone CBS−/− humans

Novel Disease-Associated Missense Single-Nucleotide Polymorphisms Variants Predication by Algorithms Tools and Molecular Dynamics Simulation of Human TCIRG1 Gene Causing Congenital Neutropenia and Osteopetrosis

A Novel CDC42 Variant with Impaired Thymopoiesis, IL-7R Signaling, PAK1 Binding, and TCR Repertoire Diversity

Case report: Comprehensive clinical, pathological and genetic investigations to decipher the background of cyclic thrombocytopenia

Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT

Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells

Novel chymotrypsin C (CTRC) variants from real-world genetic testing of pediatric chronic pancreatitis cases

CCNK gene deficiency influences neural progenitor cells via Wnt5a signaling in CCNK‐related syndrome

Using CRISPR/Cas9 genome editing in human iPSCs for deciphering the pathogenicity of a novel CCM1 transcription start site deletion

TRAF3 and NBR1 both influence the effect of the disease‐causing CYLD(Arg936X) mutation on NF‐κB activity

Generation of human induced pluripotent stem cell (hiPSC) lines derived from three patients carrying the pathogenic CRYAB (A527G) mutation and one non-carrier family member

Two heterozygous mutations in the calcium/calmodulin‐dependent serine protein kinase gene (CASK) in cases with developmental disorders

A Novel STK4 Mutation Impairs T Cell Immunity Through Dysregulation of Cytokine-Induced Adhesion and Chemotaxis Genes

Generation of a heterozygous Calsequestrin 2 F189L iPSC line (UMGi158-B) by CRISPR/Cas9 genome editing to investigate the cardiac pathophysiology of Takotsubo Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia

Dissecting CASK: Novel splice site variant associated with male MICPCH phenotype